Cargando…
Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
BACKGROUND: There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus essential in stemming persistent childhood illnesses. The third dose of pentavalen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040218/ https://www.ncbi.nlm.nih.gov/pubmed/35468754 http://dx.doi.org/10.1186/s12889-022-12570-w |
_version_ | 1784694289785159680 |
---|---|
author | Ogero, Morris Orwa, James Odhiambo, Rachael Agoi, Felix Lusambili, Adelaide Obure, Jerim Temmerman, Marleen Luchters, Stanley Ngugi, Anthony |
author_facet | Ogero, Morris Orwa, James Odhiambo, Rachael Agoi, Felix Lusambili, Adelaide Obure, Jerim Temmerman, Marleen Luchters, Stanley Ngugi, Anthony |
author_sort | Ogero, Morris |
collection | PubMed |
description | BACKGROUND: There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus essential in stemming persistent childhood illnesses. The third dose of pentavalent vaccine for children is an important indicator for assessing performance of the immunisation programme because it mirrors the completeness of a child’s immunisation schedule. Spatial access to an immunizing health facility, especially in sub-Sahara African (SSA) countries, is a significant determinant of Pentavalent 3 vaccination coverage, as the vaccine is mainly administered during routine immunisation schedules at health facilities. Rural areas and densely populated informal settlements are most affected by poor access to healthcare services. We therefore sought to determine vaccination coverage of Pentavalent 3, estimate the travel time to health facilities offering immunisation services, and explore its effect on immunisation coverage in one of the predominantly rural counties on the coast of Kenya. METHODS: We used longitudinal survey data from the health demographic surveillance system implemented in Kaloleni and Rabai Sub-counties in Kenya. To compute the geographical accessibility, we used coordinates of health facilities offering immunisation services, information on land cover, digital elevation models, and road networks of the study area. We then fitted a hierarchical Bayesian multivariable model to explore the effect of travel time on pentavalent vaccine coverage adjusting for confounding factors identified a priori. RESULTS: Overall coverage of pentavalent vaccine was at 77.3%. The median travel time to a health facility was 41 min (IQR = 18–65) and a total of 1266 (28.5%) children lived more than one-hour of travel-time to a health facility. Geographical access to health facilities significantly affected pentavalent vaccination coverage, with travel times of more than one hour being significantly associated with reduced odds of vaccination (AOR = 0.84 (95% CI 0.74 – 0.94). CONCLUSION: Increased travel time significantly affects immunization in this rural community. Improving road networks, establishing new health centres and/or stepping up health outreach activities that include vaccinations in hard-to-reach areas within the county could improve immunisation coverage. These data may be useful in guiding the local department of health on appropriate location of planned immunization centres. |
format | Online Article Text |
id | pubmed-9040218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90402182022-04-27 Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County Ogero, Morris Orwa, James Odhiambo, Rachael Agoi, Felix Lusambili, Adelaide Obure, Jerim Temmerman, Marleen Luchters, Stanley Ngugi, Anthony BMC Public Health Research Article BACKGROUND: There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus essential in stemming persistent childhood illnesses. The third dose of pentavalent vaccine for children is an important indicator for assessing performance of the immunisation programme because it mirrors the completeness of a child’s immunisation schedule. Spatial access to an immunizing health facility, especially in sub-Sahara African (SSA) countries, is a significant determinant of Pentavalent 3 vaccination coverage, as the vaccine is mainly administered during routine immunisation schedules at health facilities. Rural areas and densely populated informal settlements are most affected by poor access to healthcare services. We therefore sought to determine vaccination coverage of Pentavalent 3, estimate the travel time to health facilities offering immunisation services, and explore its effect on immunisation coverage in one of the predominantly rural counties on the coast of Kenya. METHODS: We used longitudinal survey data from the health demographic surveillance system implemented in Kaloleni and Rabai Sub-counties in Kenya. To compute the geographical accessibility, we used coordinates of health facilities offering immunisation services, information on land cover, digital elevation models, and road networks of the study area. We then fitted a hierarchical Bayesian multivariable model to explore the effect of travel time on pentavalent vaccine coverage adjusting for confounding factors identified a priori. RESULTS: Overall coverage of pentavalent vaccine was at 77.3%. The median travel time to a health facility was 41 min (IQR = 18–65) and a total of 1266 (28.5%) children lived more than one-hour of travel-time to a health facility. Geographical access to health facilities significantly affected pentavalent vaccination coverage, with travel times of more than one hour being significantly associated with reduced odds of vaccination (AOR = 0.84 (95% CI 0.74 – 0.94). CONCLUSION: Increased travel time significantly affects immunization in this rural community. Improving road networks, establishing new health centres and/or stepping up health outreach activities that include vaccinations in hard-to-reach areas within the county could improve immunisation coverage. These data may be useful in guiding the local department of health on appropriate location of planned immunization centres. BioMed Central 2022-04-25 /pmc/articles/PMC9040218/ /pubmed/35468754 http://dx.doi.org/10.1186/s12889-022-12570-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Ogero, Morris Orwa, James Odhiambo, Rachael Agoi, Felix Lusambili, Adelaide Obure, Jerim Temmerman, Marleen Luchters, Stanley Ngugi, Anthony Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County |
title | Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County |
title_full | Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County |
title_fullStr | Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County |
title_full_unstemmed | Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County |
title_short | Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County |
title_sort | pentavalent vaccination in kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in kilifi county |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040218/ https://www.ncbi.nlm.nih.gov/pubmed/35468754 http://dx.doi.org/10.1186/s12889-022-12570-w |
work_keys_str_mv | AT ogeromorris pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT orwajames pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT odhiamborachael pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT agoifelix pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT lusambiliadelaide pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT oburejerim pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT temmermanmarleen pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT luchtersstanley pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty AT ngugianthony pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty |